2024-08-01 2025-07-31 2025-07-31 false 14984576 R&R AESTHETICS LIMITED 96020Hairdressing and other beauty treatment iso4217:GBP xbrli:pure 149845762024-08-01 149845762025-07-31 149845762024-08-01 2025-07-31 14984576bus:SmallEntities2024-08-01 2025-07-31 14984576bus:AuditExempt-NoAccountantsReport2024-08-01 2025-07-31 14984576bus:FullAccounts2024-08-01 2025-07-31 14984576core:WithinOneYear2025-07-31 14984576core:AfterOneYear2025-07-31 14984576core:WithinOneYear2024-08-01 2025-07-31 14984576core:AfterOneYear2024-08-01 2025-07-31 14984576core:CurrentFinancialInstruments2025-07-31 14984576core:Non-currentFinancialInstruments2025-07-31 14984576core:CurrentFinancialInstruments2024-08-01 2025-07-31 14984576core:Non-currentFinancialInstruments2024-08-01 2025-07-31 14984576core:LandBuildings2024-08-01 2025-07-31 14984576core:FurnitureFittings2024-08-01 2025-07-31 14984576core:OfficeEquipment2024-08-01 2025-07-31 14984576core:Vehicles2024-08-01 2025-07-31 14984576core:PlantMachinery2024-08-01 2025-07-31 14984576core:OtherPropertyPlantEquipment2024-08-01 2025-07-31 14984576core:LandBuildings2025-07-31 14984576core:PlantMachinery2025-07-31 14984576core:Vehicles2025-07-31 14984576core:FurnitureFittings2025-07-31 14984576core:OfficeEquipment2025-07-31 14984576core:OtherPropertyPlantEquipment2025-07-31 14984576core:Right-of-useAssets2024-08-01 2025-07-31 14984576core:Right-of-useAssets2025-07-31 14984576core:Goodwill2024-08-01 2025-07-31 14984576core:PatentsTrademarksLicencesConcessionsSimilar2024-08-01 2025-07-31 14984576core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-08-01 2025-07-31 14984576core:OtherResidualIntangibleAssets2024-08-01 2025-07-31 14984576core:Goodwill2025-07-31 14984576core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-07-31 14984576core:PatentsTrademarksLicencesConcessionsSimilar2025-07-31 14984576core:OtherResidualIntangibleAssets2025-07-31 14984576dpl:CostSales2024-08-01 2025-07-31 14984576dpl:AdministrativeExpenses2024-08-01 2025-07-31 14984576dpl:DistributionCosts2024-08-01 2025-07-3114984576core:ShareCapital2025-07-31 14984576core:SharePremium2025-07-31 14984576core:RevaluationReserve2025-07-31 14984576core:OtherReservesSubtotal2025-07-31 14984576core:ShareCapitalPreferenceShares2025-07-31 14984576core:CapitalRedemptionReserve2025-07-31 14984576core:OtherCapitalReserve2025-07-31 14984576core:RetainedEarningsAccumulatedLosses2025-07-3114984576core:ShareCapital2024-08-01 2025-07-31 14984576core:SharePremium2024-08-01 2025-07-31 14984576core:RevaluationReserve2024-08-01 2025-07-31 14984576core:OtherReservesSubtotal2024-08-01 2025-07-31 14984576core:RetainedEarningsAccumulatedLosses2024-08-01 2025-07-311498457612024-08-01 2025-07-31 1498457622024-08-01 2025-07-3114984576core:ShareCapital12024-08-01 2025-07-31 14984576core:ShareCapital22024-08-01 2025-07-3114984576core:SharePremium12024-08-01 2025-07-31 14984576core:SharePremium22024-08-01 2025-07-3114984576core:RevaluationReserve12024-08-01 2025-07-31 14984576core:RevaluationReserve22024-08-01 2025-07-3114984576core:RetainedEarningsAccumulatedLosses12024-08-01 2025-07-31 14984576core:RetainedEarningsAccumulatedLosses22024-08-01 2025-07-311498457612024-08-01 2025-07-3114984576core:Non-currentFinancialInstrumentscore:CostValuation2024-08-01 14984576core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-07-31 14984576core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-07-31 14984576core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-07-31 14984576core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2025-07-31 14984576core:Non-currentFinancialInstrumentscore:CostValuation2025-07-3114984576core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2024-08-01 14984576core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-07-31 14984576core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-07-31 14984576core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-07-31 14984576core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2025-07-31 14984576core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-07-31 14984576core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-07-3114984576core:Non-currentFinancialInstruments2025-07-31 14984576core:Non-currentFinancialInstruments2024-07-31149845762023-08-01 149845762024-07-31 149845762023-08-01 2024-07-31 14984576core:WithinOneYear2024-07-31 14984576core:AfterOneYear2024-07-31 14984576core:CurrentFinancialInstruments2024-07-31 14984576core:Non-currentFinancialInstruments2024-07-31 14984576core:LandBuildings2024-07-31 14984576core:PlantMachinery2024-07-31 14984576core:Vehicles2024-07-31 14984576core:FurnitureFittings2024-07-31 14984576core:OfficeEquipment2024-07-31 14984576core:OtherPropertyPlantEquipment2024-07-31 14984576core:Right-of-useAssets2024-07-31 14984576core:Goodwill2024-07-31 14984576core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-07-31 14984576core:PatentsTrademarksLicencesConcessionsSimilar2024-07-31 14984576core:OtherResidualIntangibleAssets2024-07-31 14984576dpl:AdministrativeExpenses2023-08-01 2024-07-3114984576core:ShareCapital2024-07-31 14984576core:SharePremium2024-07-31 14984576core:RevaluationReserve2024-07-31 14984576core:OtherReservesSubtotal2024-07-31 14984576core:ShareCapitalPreferenceShares2024-07-31 14984576core:CapitalRedemptionReserve2024-07-31 14984576core:OtherCapitalReserve2024-07-31 14984576core:RetainedEarningsAccumulatedLosses2024-07-3114984576core:RetainedEarningsAccumulatedLosses2023-08-01 14984576core:ShareCapital2023-08-01 14984576core:SharePremium2023-08-01 14984576core:RevaluationReserve2023-08-01 14984576core:ShareCapital2023-08-01 2024-07-31 14984576core:SharePremium2023-08-01 2024-07-31 14984576core:RevaluationReserve2023-08-01 2024-07-31 14984576core:OtherReservesSubtotal2023-08-01 2024-07-31 14984576core:RetainedEarningsAccumulatedLosses2023-08-01 2024-07-3114984576bus:Director12024-08-01 2025-07-3114984576bus:PrivateLimitedCompanyLtd2024-08-01 2025-07-31
R&R AESTHETICS LIMITED
Unaudited Financial Statements
for the year ended 31 July 2025
Company registration number 14984576
(England and Wales)

Company Information

For the year ended 31 July 2025
Director Wyton, Stacey

Registered office 664 Oldham Road
Failsworth
Manchester
M35 9DU

Registered number 14984576

Accountant FD Vision Ltd t/a yourFD
1728 Davenport House
261 Bolton Road
Bury
Greater Manchester
BL8 2NZ

Statement of Financial Position

As at 31 July 2025
2025
2024
£
£
£
£
Current assets
Debtors
1,579
806
1,579
806
Creditors
Amounts falling due within one year
(3,516)
(1,801)
(3,516)
(1,801)
Net current assets (liabilities)
(1,937)
(995)
Total assets less current liabilities
(1,937)
(995)
Creditors
Amounts falling due after one year
3,175
2,173
3,175
2,173
Net assets (liabilities)
1,238
1,178
Capital and reserves
Called up share capital
100
100
Profit and loss account
1,138
1,078
Total equity
1,238
1,178

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 20 April 2026 and are signed on its behalf by:

Wyton, Stacey
Wyton, Stacey
Director

Company registration number 14984576

Notes to the Financial Statements

For the year ended 31 July 2025

1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

3. Employees

The average number of employees during the year was 2 (2024: 2).